On September 7th, Yaping Li, Chairman of the Standing Committee of Suzhou Municipal People's Congress, Xianghua Wen, Vice Chairman of the Standing Committee of Suzhou Municipal People's Congress, and Qiao Zhang, Deputy Mayor of Suzhou, visited RainMed Medical to inspect the progress of the implementation of the proposal "Promoting the Deep Integration of Innovation Chain, Industry Chain, Capital Chain and Talent Chain, and Creating the Optimal Industrial Innovation Ecology". Yunfei Huo, Chairman of the Board, Executive Director and CEO of RainMed Medical, Kangjian Liu, Vice President and Secretary of the Board of RainMed Medical, Chang Zhou, Vice President of RainMed Medical, and Yang Gu, Vice President of RainMed Medical accompanied the visit.

As a national high-tech enterprise, RainMed Medical has excellent product innovation capabilities and a top-notch R&D team. The company has differentiated itself by covering the entire process of diagnosis and treatment with vascular intervention surgical robots, and has launched a series of industry-disruptive products for precise diagnosis of vascular diseases, promoting China's precision medicine to new heights. With outstanding achievements in scientific research and talent development, RainMed Medical has stood out among many enterprises and has been showcased as a typical case of "Four Chains" deep integration.

During the visit, Mr. Yunfei Huo introduced the company's development history, talent team, academic achievements, product matrix, production capacity, and marketing to the leaders. He also demonstrated the operation of cutting-edge vascular disease diagnosis and treatment products such as the caFFR system, caIMR system, and shockwave balloon. Chairman Yaping Li highly praised RainMed Medical's comprehensive strength and fully affirmed its leadership and demonstration role in implementing the "Four Chains" proposal. He encouraged high-tech enterprises led by RainMed Medical to continue to maintain scientific research innovation, play a leading role in driving the innovation chain, and provide strong impetus for deepening the reform of "Four Chains" integration.

Mr. Kangjian Liu gave a detailed introduction to the clinical progress and value of RainMed Medical's products. Currently, RainMed Medical's product matrix continues to expand, and its R&D products have achieved phased clinical progress. These self-developed innovative functional diagnostic and therapeutic products can greatly alleviate the uneven distribution of medical resources in China, and enable primary medical institutions to have a high standard and homogeneous level of medical care. Deputy Mayor Qiao Zhang affirmed RainMed's R&D efficiency and encouraged RainMed Medical to continue to focus on scientific research innovation, not to forget its original intention of benefiting clinical practice, and to continue to bring more advanced diagnosis and treatment technologies to patients with vascular disease.

Secretary-General Ji Huang and Deputy Secretary-General Zhongmin You of the Standing Committee of Suzhou Municipal People's Congress, Jian Zhang, member of the Party Group of Suzhou Municipal Government, Xuerong Chen, Deputy Minister of the Organization Department of Suzhou Municipal Committee, Hao Gu, Chairman of the Financial and Economic Committee of Suzhou Municipal People's Congress, Jiming Xu, Director of Suzhou Municipal Science and Technology Bureau, Haidong Xu, Deputy Director of Suzhou Municipal Development and Reform Commission, Lixian Zhang, Deputy Director of Suzhou Local Financial Regulatory Bureau, Suzhou Municipal People's Congress representative Jianqiang Cao, and Hong Wu, Director of Suzhou Industrial Park Administrative Committee and other relevant leaders participated in this research.